Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMY2A | P04746 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.40 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.40 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.40 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.40 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.40 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.39 |
| ▸ | FBP1 | P09467 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9407636 | 0.85 | PYGB (0.38) | AMY2ACA2SLC2A1GAALGALS3 | |
| SCHEMBL19266321 | 0.85 | SLC2A1 (0.54) | CA2SLC2A1GAALGALS3LGALS8 | |
| SCHEMBL19266258 | 0.85 | SLC2A1 (0.54) | CA2SLC2A1GAALGALS3LGALS8 | |
| SCHEMBL9407633 | 0.82 | L3MBTL1 (0.47) | AMY2AGAALGALS3LGALS8LGALS4 | |
| Melibiose SCHEMBL29542815 | 0.82 | GAA (0.59) | AMY2ACA2GAALGALS3LGALS8 | |
| SCHEMBL22375536 | 0.81 | LGALS3 (0.60) | AMY2ACA2GAALGALS3LGALS8 | |
| SCHEMBL21243215 | 0.81 | LGALS3 (0.60) | AMY2ACA2GAALGALS3LGALS8 | |
| SCHEMBL22738734 | 0.81 | LGALS8 (0.53) | AMY2ALGALS3LGALS8LGALS4CD209 | |
| Melibiose SCHEMBL24013212 | 0.80 | GAA (0.61) | AMY2ACA2GAALGALS3LGALS8 | |
| Melibiose SCHEMBL21356840 | 0.80 | GAA (0.61) | AMY2ACA2GAALGALS3LGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140295566-A1 | CARBOHYDRATE-LIGAND CONJUGATES AND THEIR APPLICATION FOR THE ANALYSIS OF CARBOHYDRATE-PROTEIN INTERACTION | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140295566-A1 | CARBOHYDRATE-LIGAND CONJUGATES AND THEIR APPLICATION FOR THE ANALYSIS OF CARBOHYDRATE-PROTEIN INTERACTION | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2014-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140295566-A1 | CARBOHYDRATE-LIGAND CONJUGATES AND THEIR APPLICATION FOR THE ANALYSIS OF CARBOHYDRATE-PROTEIN INTERACTION | CA11, CA14, OSTC | AMY2A 276/4885CA2 620/4885SLC2A1 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.